Health Care

Trivitron’s NeoMass AAAC Kit to better Newborn Screening

With technology bringing about wonders in almost every spheres of life and every field, here is one more addition to it which Trivitron has brought about in the field of healthcare. Trivitron Healthcare, one of the largest company in Medical Technology Space of Indian Origin has has come up with NeoMass AAAC Kit (CE Approved) for better Newborn Screening in India.

Detection of any kind of anomalies at the time of child bith is important as this would prevent the kid from a bigger healthcare issue in future. NeoMass AAAC Kit is the first kit in the Global market that can detect up to 50 disorders that a newborn baby might be born with or without any immediate symptoms or visible manifestations, making it the broadest available panel of biomarkers. The launch of NeoMass AAAC Kit makes Trivitron a complete solution provider for NBS with Modular Systems, Automated Systems and Kits for core panel screening and Tandem MS/MS and NeoMass AAAC kit for expanded panel screening.

Trivitron aims to create awareness among the target audience about Newborn screening and its alarming need to make it mandatory in India too like other countries. The testing process involves pricking the heel of a newborn baby to collect a few drops of blood on a filter paper within 72 hours of birth and test for detection of life threatening disorders. The launch of NeoMass AAAC kit would lead to screening of inborn metabolic disorders based on a technology called tandem mass spectrometry which allows fast and accurate determination of metabolic disorders. The newly patented NeoMass AAAC kit uses tandem mass spectrometry technology.

Dr. GSK Velu, Chairman and Managing Director of Trivitron Group of Companies said, “Trivitron Healthcare is one of the largest provider for Newborn screening solutions in the world and our new patented NeoMass AAAC kit is the first kit in the world to detect up to 50 disorder. Trivitron Healthcare is always at the forefront of developing affordable technologies for Indian market.

This new test using the NeoMass AAAC kit makes it possible to detect deficiencies of all the six enzymes involved in the urea cycle metabolic pathway. The urea cycle is a metabolic pathway occurring in the liver and kidney and aberrant functions of the urea cycle enzymes lead to the buildup of ammonia, a product of protein metabolism. If not treated the outcome is very serious with symptoms ranging from vomiting and increasing lethargy to respiratory distress and even coma and death. Additionally NeoMass AAAC enables an easy and reliable detection of type I tyrosinemia, a serious disease causing dermatologic and neuro developmental problems due to accumulation of tyrosine within the liver and kidney.

Previous post

DIGISOL launches Mi-Fi Broadband Router with 4G support

Next post

Blubirch Pioneers in end-to-end IT/Technology Reverse Logistic Services

Luna Dewan

Luna Dewan

With six years of her journalism experience, Luna Dewan has worked for leading print media like the New Indian Express, Deccan Chronicle and DNA. She has been writing on healthcare, environment and various other civic issues. She is now with as the Assistant Editor.

No Comment

Leave a reply

Your email address will not be published. Required fields are marked *